Patrick W. Serruys, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Xeltis(MODEST), SMT(MODEST), Meril(MODEST), Philips(MODEST), Novartis Corporation(NONE)

View Full Disclosure